Shockwave Medical

#DisruptBTKII enrolled the largest cohort of real-world, complex patients to date — no other technology has been evaluated in such severely calcified BTK lesions or in such a challenging patient population to date. For example, of the CLTI cohort, 18% were on dialysis, 73% had wounds at baseline and 31% had chronic total occlusions. Watch lead investigator Dr. Venita Chandra discuss these and other findings from this study:  #clti-video" target="_blank" rel="nofollow noopener">shockwavemedical.com/clinical-evide…  US Rx only. ISI bit.ly/3iEq7fC

Congratulations to Dr. @OlgaTolevaMD and the Cardiovascular Research Team at Northeast Georgia Medical Center (@ngmcgme) for joining the growing number of #COSIRAII enrolling sites and successfully enrolling their first two single‑arm patients in the trial. Have questions about the COSIRA-II trial and participating sites? Learn more on our website:  shockwavemedical.com/clinical-evide… ISI bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use.

Mission accomplished at the Calcium Roundtable in Rome! 🎯 With fresh evidence from the IVLiac registry and a deep dive into real-world complex #ShockwaveIVL cases, Prof Stefano Fazzini and Dr Giacomo Isernia led an inspiring program on how to tackle some of the toughest iliac and fem-pop calcium challenges. Presenting physicians are paid consultants of Shockwave Medical. US Rx only. ISI bit.ly/3iEq7fC #CalciumRoundtable #IliacCalcification #FemPopCalcification

Make waves with us at #OEIS 2026! Stop by the Tech Forum Workshop on Thursday afternoon in the Palace Ballroom for some hands-on experience with #ShockwaveIVL and learn the latest updates on OBL Reimbursement! Add it to your calendar: addevent.com/event/gzgynrmj…  US Rx only. Important Safety Information: bit.ly/3iEq7fC @OEISociety

The recently published V-PAD Consensus positions #ShockwaveIVL as the best first-line vessel preparation option for calcified above-the-knee lesions (>75% agreement). With consistent support across all calcium morphologies, this paper reinforces IVL’s role as a safe & effective technology in endovascular treatment. Read the full publication and hear lead author Prof. @a_saratzis break down the real-world impact of the V-PAD Consensus: shockwavemedical.com/en-eu/educatio…  Prof. Saratzis is a paid consultant of Shockwave Medical. US Rx only. ISI bit.ly/3iEq7fC

#EMPOWERCAD's low rate of angiographic complications confirms #ShockwaveIVL's consistent safety profile in a real-world female population with complex calcium. Learn more about this first-of-its-kind study:  shockwavemedical.com/clinical-evide…  US Rx only. ISI bit.ly/3iEq7fC

Don't miss the latest BackTable VI podcast episode featuring Dr Paul Foley! He'll discuss #DisruptBTKII data, including the importance of the study’s CLTI outcomes due to the chronic lack of data on this complex patient population. Dr Foley will also share his #ShockwaveJavelin algorithm and techniques as well as his real-world experience with the device. An absolute must-listen if you want to better understand when to pull Shockwave Javelin into your interventions. Dr Foley is a paid consultant of Shockwave Medical. US Rx only. ISI bit.ly/3iEq7fC @_backtable

BALI RCT demonstrates that the use of #ShockwaveIVL before stent implantation in patients undergoing PCI for severely calcified coronary lesions reduced the incidence of procedural failure or target vessel failure at 1 year, without an increased risk of adverse events. Dive into the details by reading the open-access publication on JACC:CI — jacc.org/doi/10.1016/j.…  US Rx only. ISI bit.ly/3iEq7fC  @JACCJournals

#DisruptBTKII sets a new benchmark for what’s possible in real-world, complex patients with moderate-to-severe BTK calcium. Watch as lead investigator Dr. Venita Chandra discusses how using #ShockwaveIVL as a frontline calcium modification strategy helps improve patient outcomes — including improving quality of life and reducing amputation risk. See the 12-month outcomes symposium now: #clti-video" target="_blank" rel="nofollow noopener">shockwavemedical.com/clinical-evide… US Rx only. ISI bit.ly/3iEq7fC

Female patients with calcified CAD are underdiagnosed, underrepresented, and typically have underwhelming outcomes. Newly published #EMPOWERCAD results show that #CoronaryIVL is a safe, effective first-line therapy for this complex cohort. Learn more about EMPOWER CAD:  shockwavemedical.com/clinical-evide…  US Rx only. ISI bit.ly/3iEq7fC

Kudos to Dr. @dr_tkot, Dr. Gerry Coghlan, and Proctor Prof @rallamee, as well as the team at the Royal Free Hospital (@RoyalFreeNHS) in London for their participation in the COSIRA‑II study, joining the growing number of #COSIRAII enrolling sites and completing one single‑arm patient and one randomized patient for the COSIRA‑II trial in the UK! To learn more about the COSIRA‑II trial and the participating sites visit: shockwavemedical.com/en-eu//clinica… ISI bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use.

Two-thirds of BALI RCT patients with routine #ShockwaveIVL were free of the primary endpoint, compared with approximately half of patients in the conventional treatment arm. This led the investigators to determine that adding Shockwave IVL to lesion preparation before stent implantation in severely calcified lesions proved superior to conventional strategies alone. Learn more about this groundbreaking study:  shockwavemedical.com/education/bali… US Rx only. ISI bit.ly/3iEq7fC

For International Physicians: Congratulations to Prof. Vavouranakis, Dr. Kyvelou, and the entire team at the Sotiria General Hospital for Chest Diseases in Athens, Greece, who have recently launched their #ShockwaveReducer Program, an innovative approach to treating patients suffering from chronic refractory angina! Under the proctorship of Professor Konigstein, the team successfully initiated the program with their first two patients, marking an important step forward in expanding access to this cutting‑edge therapy for patients with chronic, refractory chest pain. Stay tuned as we continue to grow this program and improve the lives of patients living with refractory angina. Learn more about the Shockwave Reducer on our website: shockwavemedical.com/en-eu/products… ISI bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

Our #ShockwaveIVL symposium at #CRT2026 is a wrap! We hope you’re thinking differently about calcium modification and ready to make big waves in your daily practice. Special shout out to the incredible physicians who shared their knowledge with us, Drs Jai Khatri, Daniel Kiss, @ziadalinyc and @HannahChaudryMD. We appreciate you so much! Presenting physicians are paid consultants. US Rx only. ISI bit.ly/3iEq7fC

We're excited to see the continued momentum behind the use of #ShockwaveIVL for #BTK disease treatment. Thank you to Dr @EricSecemskyMD for presenting the 12-mo outcomes from the #DisruptBTKII study, highlighting the strength of the data in a particularly complex patient cohort, at #CRT2026 in Washington, DC. Learn more: shockwavemedical.com/clinical-evide… Dr Secemsky is a paid consultant of Shockwave Medical. US Rx only. ISI bit.ly/3iEq7fC

Why did we need this consensus? Prof @a_saratzis, one of the publication authors, explains why expert alignment on vessel preparation for PAD treatment was essential—and why #ShockwaveIVL now defines first-line care. Read the full publication and learn more: shockwavemedical.com/en-eu/educatio…  US Rx only. ISI bit.ly/3iEq7fC #ExpertVoices #IVLConsensus

At #CRT2026, Dr @JDCorlMD presented a case featuring #ShockwaveJavelin in a 68M with CLTI and osteomyelitis. Via right posterior tibial access, #ShockwaveIVL was delivered to both the right anterior and posterior tibial arteries to enable further treatment, highlighting the versatility of #ShockwaveJavelin in multi-vessel BTK disease. Learn more about Shockwave Javelin: shockwavemedical.com/products/shock… Dr Corl is a paid consultant of Shockwave Medical. US Rx only. ISI bit.ly/3iEq7fC @CRT_meeting

#CRT2026 attendees — do you know all the shocking benefits #ShockwaveIVL brings to your practice and your patients? Join us on Monday March 9th at 12:30pm to take an in-depth look at our MOA, hear best practices and meet the new #ShockwaveC2Aero during our symposium, Advances in Imaging and Calcium Modification. Don't miss this energizing event featuring Drs Jai Khatri, Daniel Kiss, @ziadalinyc and @HannahChaudryMD. Add it to your calendar today: addevent.com/event/83vfygh0…  US Rx only. ISI bit.ly/3iEq7fC

Safety is our DNA and MOA and that holds true with faster pulsing: The CAD Duo late breaker at #CRT2026 confirmed non-inferior safety and efficacy for #ShockwaveIVL at 2Hz. Thank you to Dr. @matthewjpricemd for presenting the primary endpoint and 6-month results of the #DisruptCAD Duo IDE study today. Read the publication in @JACCJournals here: jacc.org/doi/10.1016/j.… Congratulations on the simultaneous publication in JACC:CI, a huge feat! Drs @matthewjpricemd, Nick West, Dominic Allocco, @RhianEDavies1, Richard Shlofmitz, Michael Kim, Torrey Schmidt, Jonathan Roberts, Abdullahi Oseni, Salvatore Mannino, Demetrios Doukas, and Mark Johnson. US Rx only. ISI bit.ly/3iEq7fC @CRT_meeting

BALI RCT findings continue to confirm #ShockwaveIVL’s predictable safety with a low risk of device-related complications. Watch as lead investigator Prof. Niels Thue Olsen discusses the study’s unique design and results with #ShockwaveMedical’s Chief Medical Officer, Dr. Nick West: shockwavemedical.com/education/bali…  US Rx only. ISI bit.ly/3iEq7fC